AIA

:   angiogenesis-inhibiting agents

BAD

:   Bcl-2-associated death promoter

Bcl-2

:   B-cell lymphoma 2

Bcl-xl

:   B-cell lymphoma extra large

CA-1

:   combretastatin A-1

CA-2

:   combretastatin A-2

CA-3

:   combretastatin A-3

CA-4

:   combretastatin A-4

CA-1P

:   combretastatin A-1 diphosphate, OXi4503

CA-4P

:   combretastatin A-4 phosphate, Zybrestat

CB-1

:   combretastatin B-1

CB-2

:   combretastatin B-2

CDC2

:   cell division control protein 2

CDK1

:   cyclin-dependent kinase 1

CoMFA

:   comparative molecular field analysis

DAMA-colchicine

:   N-deacetyl-N-(2-mercaptoacetyl)-colchicine

ERK

:   extracellular signal-regulated kinase

GTP

:   guanosine-5′-triphosphate

GDP

:   guanosine-5′-diphosphate

HIF-1α

:   hypoxiainducible factor 1α

HNSCC

:   head and neck squamous cell carcinoma

HUVECs

:   human umbilical vein endothelial cells

iNOS

:   inducible nitric oxide synthase

JNK

:   c-Jun N-terminal kinase

LY290181

:   2-amino-4-(3-pyridyl)-4*H*-naphtho(1,2-b)pyran-3-carbonitrile

MAPs

:   microtubule-associated proteins

MAPKs

:   mitogen-activated protein kinases

MIA

:   microtubule-interfering agents

MRP-1

:   multidrug resistance protein 1

MRP-3

:   multidrug resistance protein 3

SAR

:   structure-activity relationship

SPA

:   Special Protocol Assessment

+TIPs

:   plus-and-tracking proteins

VDAs

:   vascular disrupting agents

VEGF

:   vascular endothelial growth factor

VEGFR2

:   VEGF receptor 2

VTAs

:   vascular targeting agents
